Proposed de fi nitions of antibody-mediated rejection for use as a clinical trial endpoint in kidney transplantation

HIGHLIGHTS

• who: EMA guideline and collaborators from the Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom, Institute of Pathology, University Cologne, Cologne, Germany, Department of Pathology, Hu00f4pital have published the research: Proposed De fi nitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation, in the Journal: (JOURNAL) of 21/Oct/2021
• what: This paper was Organ (ESOT) to the European Medicines Agency (EMA) which explored whether updating guidelines on clinical trial endpoints would encourage innovations in kidney research.
• future: Future research . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.